Clinical Trial Update: Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating immunoscintigraphy with a radiolabeled monoclonal antibody to detect tumor cells in colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Radiolabeled monoclonal antibody

Snippet

Sponsor: City of Hope Medical Center | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED